Table 2
Invasive Cancer Incidence by Primary Site and Age at Diagnosis
Michigan Residents, 2018

Primary Site
  (ICD-O-3 Cancer Incidence
Site Groupings)
 
Total Less than 50 Years 50 - 74 Years 75 Years & Over
Number Age-
Adjusted
Rate
Number Age-
Specific
Rate
Number Age-
Specific
Rate
Number Age-
Specific
Rate
Gastrointestinal Tract
& Digestive System
11,318 87.7 ±1.6 997 16.1 ±1.0 7,045 229.7 ±5.2 3,276 461.5 ±14.9
Lip, Oral Cavity & Pharynx 1,594 12.2 ±0.6 176 2.8 ±0.4 1,122 36.6 ±2.1 296 41.7 ±4.7
Stomach 757 5.9 ±0.4 62 1.0 ±0.2 447 14.6 ±1.3 248 34.9 ±4.3
Colon 3,221 25.6 ±0.9 320 5.2 ±0.6 1,771 57.8 ±2.7 1,130 159.2 ±9.1
Rectum 1,446 11.6 ±0.6 196 3.2 ±0.4 942 30.7 ±2.0 308 43.4 ±4.8
Pancreas 1,771 13.4 ±0.6 74 1.2 ±0.3 1,090 35.5 ±2.1 607 85.5 ±6.7
Other Gastrointestinal
Tract & Digestive System
2,529 19.1 ±0.7 169 2.7 ±0.4 1,673 54.6 ±2.6 687 96.8 ±7.2
Respiratory System &
Pleura
8,581 63.7 ±1.3 236 3.8 ±0.5 5,602 182.7 ±4.7 2,743 386.4 ±13.8
Larynx 446 3.3 ±0.3 27 0.4 ±0.2 324 10.6 ±1.2 95 13.4 ±2.7
Lung & Bronchus 8,036 59.6 ±1.3 187 3.0 ±0.4 5,224 170.4 ±4.5 2,625 369.8 ±13.5
Other Respiratory 99 0.8 ±0.2 22 0.4 ±0.2 54 1.8 ±0.5 23 3.2 ±1.3
Bones & Soft Tissue 447 4.0 ±0.4 161 2.6 ±0.4 201 6.6 ±0.9 85 12.0 ±2.5
Melanoma of Skin 2,485 20.6 ±0.8 481 7.7 ±0.7 1,427 46.5 ±2.4 577 81.3 ±6.6
Breast 8,370 67.8 ±1.5 1,316 21.2 ±1.1 5,310 173.2 ±4.6 1,744 245.7 ±11.2
Genitourinary Organs 15,764 118.9 ±1.9 1,277 20.6 ±1.1 10,930 356.4 ±6.4 3,557 501.1 ±15.5
Cervix Uteri 357 3.7 ±0.4 200 3.2 ±0.4 132 4.3 ±0.7 25 3.5 ±1.4
Corpus Uteri 1,951 14.7 ±0.7 194 3.1 ±0.4 1,435 46.8 ±2.4 322 45.4 ±4.9
Ovary 555 4.6 ±0.4 95 1.5 ±0.3 327 10.7 ±1.2 133 18.7 ±3.2
Prostate Gland 7,212 50.9 ±1.2 120 1.9 ±0.3 5,775 188.3 ±4.7 1,317 185.5 ±9.8
Other Genital 802 7.2 ±0.5 291 4.7 ±0.5 353 11.5 ±1.2 158 22.3 ±3.5
Urinary Bladder 2,676 20.3 ±0.7 79 1.3 ±0.3 1,477 48.2 ±2.4 1,120 157.8 ±9.1
Kidney and Renal Pelvis 2,081 16.5 ±0.7 295 4.8 ±0.5 1,365 44.5 ±2.3 421 59.3 ±5.6
Other Urinary 130 1.0 ±0.2 3 *   66 2.2 ±0.5 61 8.6 ±2.2
Brain & Other Central
Nervous System
745 6.5 ±0.5 225 3.6 ±0.5 381 12.4 ±1.2 139 19.6 ±3.2
Lymphomas 2,752 22.4 ±0.8 473 7.6 ±0.7 1,464 47.7 ±2.4 815 114.8 ±7.8
Hodgkin Lymphoma 277 2.7 ±0.3 177 2.9 ±0.4 78 2.5 ±0.6 22 3.1 ±1.3
Non-Hodgkin Lymphoma 2,475 19.7 ±0.8 296 4.8 ±0.5 1,386 45.2 ±2.4 793 111.7 ±7.7
Multiple Myeloma 824 6.4 ±0.4 67 1.1 ±0.3 489 15.9 ±1.4 268 37.8 ±4.5
Leukemias 1,632 13.2 ±0.6 253 4.1 ±0.5 839 27.4 ±1.8 540 76.1 ±6.4
All Other 3,587 30.3 ±1.0 783 12.6 ±0.9 1,701 55.5 ±2.6 1,103 155.4 ±9.0
Total 56,505 441.6 ±3.5 6,269 101.0 ±2.4 35,389 1,154.1 ±10.4 14,847 2,091.6 ±25.7
               

Notes: Age-Specific Rates are per 100,000 population in a specific age group. Age-Adjusted Rates are per 100,000 population. Age-adjusted rates are computed by the direct method, using as the standard population the age distribution of the total population of the United States for the year 2000. Adding and subtracting the number shown after the ± symbol from the rate creates a confidence interval indicating that the true rate lies between the lower and upper bounds of this interval with 95 % statistical confidence.
Case : A case is defined as a person with any newly diagnosed cancer with a behavior code of 3 (malignant primary site). Both in-situ and invasive urinary bladder cancer cases are included, in order to be consistent with SEER tabulations from the National Cancer Institute.
* : A rate is not calculated when there are fewer than 20 total events, or fewer than 6 events in an age category, because the width of the confidence interval would negate any usefulness for comparative purposes.
Source: Michigan Resident Cancer Incidence File. Updated with cases processed through November 30, 2020. Division for Vital Records & Health Statistics, Michigan Department of Health & Human Services.
Last Updated: May 20, 2021